{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:30:32Z","timestamp":1790260232739,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/L024012\/1"],"award-info":[{"award-number":["EP\/L024012\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C552\/A17720"],"award-info":[{"award-number":["C552\/A17720"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/mt.2015.233","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T07:20:31Z","timestamp":1451287231000},"page":"796-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth"],"prefix":"10.1016","volume":"24","author":[{"given":"Alison","family":"Tedcastle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Illingworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard W","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry D","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.233_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2015.233_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.gt.3301377","article-title":"Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?","volume":"8","author":"Kirn","year":"2001","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.233_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncponc0736","article-title":"Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress","volume":"4","author":"Liu","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/mt.2015.233_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.cgt.7701080","article-title":"A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients","volume":"14","author":"Nemunaitis","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.233_bib5","doi-asserted-by":"crossref","first-page":"iv361","DOI":"10.1093\/annonc\/mdu342.21","article-title":"A phase 1 mechanism of action study of intra-tumoural (IT) or intravenous (IV) administration of enadenotucirev, an oncolytic Ad11\/Ad3 chimeric group B adenovirus","volume":"25","author":"Boni","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1038\/mt.2015.233_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.3103","article-title":"A first-in-class, first-in-human phase I study of enadenotucirev, an oncolytic Ad11\/Ad3 chimeric group B adenovirus, administered intravenously in patients with metastatic epithelial tumors","volume":"32","author":"Calvo","year":"2014","journal-title":"J Clinical Oncol"},{"key":"10.1038\/mt.2015.233_bib7","first-page":"2497","article-title":"Role of extracellular matrix assembly in interstitial transport in solid tumors","volume":"60","author":"Netti","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.233_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/104303403321467199","article-title":"Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points","volume":"14","author":"Sauthoff","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.233_bib9","first-page":"1","article-title":"Effects of ECM Proteins on Barrier Formation in Caco-2 Cells","volume":"421","author":"Swiderek","year":"1997","journal-title":"Becton Dickinson Technical Bulletin"},{"key":"10.1038\/mt.2015.233_bib10","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1158\/1078-0432.CCR-08-2082","article-title":"Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy","volume":"15","author":"Mok","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.233_bib11","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/sj.mt.6300264","article-title":"Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus","volume":"15","author":"Cheng","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.233_bib12","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1089\/104303400750035744","article-title":"Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy","volume":"11","author":"Kuriyama","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.233_bib13","first-page":"3503","article-title":"Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase","volume":"20","author":"Brekken","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1038\/mt.2015.233_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.10668","article-title":"Hyaluronidase reduces human breast cancer xenografts in SCID mice","volume":"102","author":"Shuster","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1038\/mt.2015.233_bib15","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-06-4260","article-title":"Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice","volume":"67","author":"Ganesh","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.233_bib16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djj397","article-title":"Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy","volume":"98","author":"Kim","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mt.2015.233_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/mt.2010.79","article-title":"Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth","volume":"18","author":"Guedan","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.233_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-7580.2004.00261.x","article-title":"Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?","volume":"204","author":"Rhodes","year":"2004","journal-title":"J Anat"},{"key":"10.1038\/mt.2015.233_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.expneurol.2007.05.001","article-title":"How does chondroitinase promote functional recovery in the damaged CNS?","volume":"206","author":"Crespo","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2015.233_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/BJ20041222","article-title":"Chondroitinase ABC I from Proteus vulgaris: cloning, recombinant expression and active site identification","volume":"386","author":"Prabhakar","year":"2005","journal-title":"Biochem J"},{"key":"10.1038\/mt.2015.233_bib21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/1078-0432.CCR-10-2213","article-title":"Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy","volume":"17","author":"Dmitrieva","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.233_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/mt.2015.233_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.yexmp.2012.09.018","article-title":"Oncosis: an important non-apoptotic mode of cell death","volume":"93","author":"Weerasinghe","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"10.1038\/mt.2015.233_bib24","series-title":"Cell Death in Mammalian Ovary","first-page":"pp. 103","article-title":"Oncosis","author":"Escobar","year":"2011"},{"key":"10.1038\/mt.2015.233_bib25","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.233_bib26","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1073\/pnas.93.16.8225","article-title":"Engineering actin-resistant human DNase I for treatment of cystic fibrosis","volume":"93","author":"Ulmer","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.233_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1432-1033.1989.tb14539.x","article-title":"Proteinase K from Tritirachium album Limber. Characterization of the chromosomal gene and expression of the cDNA in Escherichia coli","volume":"179","author":"Gunkel","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1038\/mt.2015.233_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2144\/000112993","article-title":"Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function","volume":"45","author":"Stanton","year":"2008","journal-title":"Biotechniques"},{"key":"10.1038\/mt.2015.233_bib29","doi-asserted-by":"crossref","first-page":"e1000440","DOI":"10.1371\/journal.ppat.1000440","article-title":"Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells","volume":"5","author":"Cawood","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2015.233_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1472-6750-11-124","article-title":"Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts","volume":"11","author":"Alcoser","year":"2011","journal-title":"BMC Biotechnol"},{"key":"10.1038\/mt.2015.233_bib31","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.3103","article-title":"A first-in-class, first-in-human phase I study of enadenotucirev, an oncolytic Ad11\/Ad3 chimeric group B adenovirus, administered intravenously in patients with metastatic epithelial tumors","volume":"32","author":"Calvo","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.233_bib32","doi-asserted-by":"crossref","first-page":"iv367","DOI":"10.1093\/annonc\/mdu342.17","article-title":"A phase 1 study of enadenotucirev, an oncolytic ad11\/ad3 chimeric group b adenovirus, administered intravenously-analysis of dose expansion and repeat cycle cohorts in patients with metastatic colorectal cancer (mCRC)","volume":"25","author":"Calvo","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1038\/mt.2015.233_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2015.233_bib34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.gt.3302459","article-title":"Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression","volume":"12","author":"Pipiya","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.233_bib35","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.gt.3302448","article-title":"Effect of hypoxia on Ad5 infection, transgene expression and replication","volume":"12","author":"Shen","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.233_bib36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/hum.2010.227","article-title":"Strategies to enhance viral penetration of solid tumors","volume":"22","author":"Smith","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.233_bib37","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-07-4732","article-title":"Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models","volume":"14","author":"Ganesh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.233_bib38","first-page":"1","article-title":"Dornase alfa for cystic fibrosis","volume":"3","author":"Jones","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1038\/mt.2015.233_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(01)00884-6","article-title":"Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion","volume":"416","author":"Denholm","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/mt.2015.233_bib40","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2015.233_bib41","first-page":"93","article-title":"The presence of circulating deoxyribonucleic-acid (DNA) in patients with acute or chronic leukemia-relation to serum anti-DNA antibodies and clq binding-activity","volume":"1","author":"Carpentier","year":"1981","journal-title":"Human Lymphocyte Differentiation"},{"key":"10.1038\/mt.2015.233_bib42","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S","article-title":"Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease","volume":"51","author":"Shapiro","year":"1983","journal-title":"Cancer"},{"key":"10.1038\/mt.2015.233_bib43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0277-5379(87)90266-5","article-title":"Isolation and characterization of DNA from the plasma of cancer patients","volume":"23","author":"Stroun","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1038\/mt.2015.233_bib44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000226740","article-title":"Neoplastic characteristics of the DNA found in the plasma of cancer patients","volume":"46","author":"Stroun","year":"1989","journal-title":"Oncology"},{"key":"10.1038\/mt.2015.233_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/gt.2009.142","article-title":"Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy","volume":"17","author":"Choi","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.233_bib46","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/onc.2009.415","article-title":"A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy","volume":"29","author":"Watanabe","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/mt.2015.233_bib47","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/0008-5472.CAN-12-3287","article-title":"Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis","volume":"73","author":"Wen","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.233_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.biochi.2010.12.011","article-title":"Inhibition of metastasis development by daily administration of ultralow doses of RNase A and DNase I","volume":"93","author":"Patutina","year":"2011","journal-title":"Biochimie"},{"key":"10.1038\/mt.2015.233_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bjc.1993.10","article-title":"Deoxyribonuclease treatment prevents blood-borne liver metastasis of cutaneously transplanted tumour cells in mice","volume":"67","author":"Sugihara","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1038\/mt.2015.233_bib50","doi-asserted-by":"crossref","first-page":"e2409","DOI":"10.1371\/journal.pone.0002409","article-title":"Directed evolution generates a novel oncolytic virus for the treatment of colon cancer","volume":"3","author":"Kuhn","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.233_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jconrel.2010.10.011","article-title":"Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins","volume":"150","author":"Bachtarzi","year":"2011","journal-title":"J Control Release"},{"key":"10.1038\/mt.2015.233_bib52","doi-asserted-by":"crossref","first-page":"e15576","DOI":"10.1371\/journal.pone.0015576","article-title":"Polymers for improving the in vivo transduction efficiency of AAV2 vectors","volume":"5","author":"Moulay","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.233_bib53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/sj.gt.3302736","article-title":"The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p)","volume":"13","author":"Shen","year":"2006","journal-title":"Gene Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:50:46Z","timestamp":1761501046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616310036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1525001616310036"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.233","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2015.233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}